How Do We Decide Which Drug Is Best?

Whenever possible, we need publicly funded trials for comparative effectiveness research, designed to evaluate similar drugs at comparable doses to determine their real comparative safety and efficacy. How else do we answer the question, “Is it really better?” Read more here. (Source: Robert Bohrer, HealthAffairs Blog, 2/20/15)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
Biomarkers and Companion diagnostics: Payer Insights 09/26/2019
Leveraging Technology to Reduce Costs in Clinical Trials 06/30/2019
Real World Evidence (RWE) Solutions Market by Component,… 02/05/2020
The Future of Personalised Medicine: The Role of Simulation… 01/25/2020
Pragmatic Randomized Trials: Considerations for Design and… 11/21/2019